Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. 2007

Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.

Cytokines produced by tumor cells may have various effects on antitumor immune responses and tumor growth. In the present study, the cytokine production of 31 lung cancer cell lines was evaluated, while any correlation with the histological type, the induction of tumor-specific cytotoxic T lymphocytes (CTL) in vitro, and angiogenesis and the infiltration of inflammatory cells in tumor tissues were also examined. Production of interleukin (IL)-1alpha, IL-1beta, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor, transforming growth factor (TGF)-beta and vascular endothelial growth factor (VEGF) in the culture supernatant was measured using enzyme-linked immunosorbent assay. Each cytokine was produced in a substantial number of the tumor cell lines. In particular, IL-6, IL-8, TGF-beta and VEGF were produced in 18 (55%), 29 (94%), 31 (100%) and 28 (90%) of 31 cell lines, respectively. However, neither IL-4 nor TNF-alpha was produced at all by any tumor cell line. TGF-beta production was significantly higher in adenocarcinoma than in squamous cell carcinoma (P = 0.03). Immunohistochemical staining revealed the magnitude of macrophage infiltration, and angiogenesis in surgically resected tumor tissue specimens correlated well with GM-CSF and IL-8 production from the corresponding cell lines. Among six lung cancer cell lines, CTL were induced in the three lung cancer cell lines that produced a lower amount of TGF-beta (<100 pg/mL). These findings suggested that TGF-beta produced by tumor cells could inhibit the induction of CTL in vitro. The present results suggest that the production of various cytokines from tumor cells might exert various paracrine effects both in vivo and in vitro.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
August 1995, Experimental dermatology,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
October 1963, Nature,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
October 2000, Journal of pineal research,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
September 2019, Asian cardiovascular & thoracic annals,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
April 2016, Chemosphere,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
January 2001, Anticancer research,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
January 1991, Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985),
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
October 1997, Cytokine,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
September 2002, Clinical cancer research : an official journal of the American Association for Cancer Research,
Takashi Fukuyama, and Yoshinobu Ichiki, and Sousuke Yamada, and Yoshiki Shigematsu, and Tetsuro Baba, and Yoshika Nagata, and Makiko Mizukami, and Masakazu Sugaya, and Mitsuhiro Takenoyama, and Takeshi Hanagiri, and Kenji Sugio, and Kosei Yasumoto
January 2014, PloS one,
Copied contents to your clipboard!